Skip to main content

AbbVie Inc.

ABBV
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001551152

In the last 90 days, AbbVie Inc. insiders filed 0 open-market purchases and 1 sale; 4,238 institutions reported holding it in 13F filings for Q2 2026, worth $335.4B in total; superinvestors Gardner Russo & Quinn and Harris Associates (Oakmark) hold it.

Superinvestors holding ABBV, Q2 2026

2 superinvestors report holding AbbVie Inc. on Form 13F, worth $3.73M in total. Weight is AbbVie Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding ABBV in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Gardner Russo & QuinnTom Russo<0.1%12,410$3.12MUnchanged
Harris Associates (Oakmark)Bill Nygren<0.1%2,420$609.0KReduced−9.8%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of ABBV each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    2 superinvestors holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−9.8%)
  2. Q4 2025

    2 superinvestors holding at quarter end

    Reduced
    Harris Associates (Oakmark) (−15.2%)
  3. Q2 2025

    2 superinvestors holding at quarter end

    New
    Harris Associates (Oakmark)
  4. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    Gardner Russo & Quinn (−0.8%)
  5. Q3 2024

    1 superinvestor holding at quarter end

    Sold out
    Harris Associates (Oakmark)
  6. Q2 2024

    2 superinvestors holding at quarter end

    Added
    Harris Associates (Oakmark) (+6.6%)
    Sold out
    Greenwoods Asset Management
  7. Q1 2024

    3 superinvestors holding at quarter end

    New
    Greenwoods Asset Management
    Reduced
    Harris Associates (Oakmark) (−50.0%)
  8. Q4 2023

    2 superinvestors holding at quarter end

    Reduced
    Gardner Russo & Quinn (−0.6%), Harris Associates (Oakmark) (−14.0%)
    Sold out
    Maverick Capital
  9. Q3 2023

    3 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Gardner Russo & Quinn (−0.1%)
  10. Q2 2023

    2 superinvestors holding at quarter end

    New
    Harris Associates (Oakmark)
    Reduced
    Gardner Russo & Quinn (−0.2%)
  11. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    Gardner Russo & Quinn (−2.3%)
  12. Q1 2022

    1 superinvestor holding at quarter end

    Sold out
    Berkshire Hathaway
  13. Q4 2021

    2 superinvestors holding at quarter end

    Reduced
    Berkshire Hathaway (−78.9%)
    Sold out
    Maverick Capital
  14. Q3 2021

    3 superinvestors holding at quarter end

    Added
    Gardner Russo & Quinn (+2.4%)
    Reduced
    Berkshire Hathaway (−29.9%), Maverick Capital (−18.2%)
    Sold out
    ARK Invest
  15. Q2 2021

    4 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Berkshire Hathaway (−10.2%), ARK Invest (−1.2%)